♟️ Wednesday 30 April 2025 Wed, 30 Apr 2025

RLF AgTech has secured major national distribution agreements in Australia, launched a comprehensive retail rollout, and restructured its manufacturing arm, LiquaForce, to drive growth and operational efficiency. The company also reported strong financial performance and expanded its footprint across Asia.

Toubani Resources has raised A$29 million through a strategic placement led by A2MP Investments, which also commits to a US$160 million debt facility, positioning the Kobada Gold Project for a final investment decision by late 2025.

Medallion Metals has advanced negotiations to acquire the Cosmic Boy Process Plant at Forrestania, while delivering robust drilling results at Ravensthorpe and securing a $6.5 million placement to fund its sulphide development strategy.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.

Global Lithium Resources has resumed its Definitive Feasibility Study at the Manna Lithium Project, focusing on cost optimization and project economics, while advancing heritage and native title agreements. The company also reported significant board changes and a robust cash position heading into 2025.

Beonic Limited reported a 6.5% increase in annual recurring revenue to $17.8 million and a significant gross margin improvement to 75.5%, driven by new global contracts and disciplined cost management. The company targets cash flow breakeven in Q4 FY25 and an EBITDA margin of up to 15%.

Petratherm Limited has confirmed a significant titanium-rich heavy mineral sands discovery at its Muckanippie Project, with drilling extending mineralisation over 15 square kilometres and a recent $8.1 million placement to accelerate development.

Trigg Minerals has solidified its ownership of the Wild Cattle Creek antimony deposit with NSW government approval and confirmed high-grade antimony and tungsten mineralisation beneath the site. The company also expanded its New South Wales footprint through strategic acquisitions of historic gold and antimony projects.

INOVIQ Limited reports significant progress in its exosome-based cancer diagnostics and therapeutics, including expanded customer adoption, advanced AI screening tests, and strategic partnerships with leading research centres.

Helios Energy has confirmed significant contingent resources at its Presidio Project in West Texas, supported by new technical partnerships and a strengthened leadership team. The company raised $4.3 million to advance its development plans amid a shifting US energy landscape.

Gold Hydrogen Limited is gearing up for a pivotal 2025 drilling campaign at its Ramsay Project, aiming to further appraise significant natural hydrogen and helium accumulations confirmed in prior exploration. The company also bolsters its technical team and launches a new InvestorHub to deepen stakeholder engagement.

Fin Resources Limited reported subdued exploration activity in Q1 2025 amid weak lithium prices but secured $445,000 via convertible notes and outlined plans for McKenzie Springs exploration.

Inca Minerals has secured over 94% ownership of Stunalara Metals, gaining access to the promising Hurricane Project in North Queensland. With an oversubscribed $1.1 million capital raise, maiden drilling is set to begin in Q2 2025, targeting high-grade gold and antimony mineralisation.

Westgold Resources reported a record A$80 million increase in cash, bullion, and liquid investments in Q3 FY25, maintaining steady gold production and cost guidance while advancing key mine ramp-ups and strategic divestments.

European Lithium Limited reports a maiden 45 million tonne rare earth resource at its Greenland Tanbreez Project, alongside a $24.5 million capital raise by its majority-owned Critical Metals Corp, underpinning its global lithium and rare earth ambitions.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

Aldoro Resources has reported significant assay results from its Kameelburg project in Namibia, confirming a large polymetallic deposit rich in rare earth elements, niobium, and molybdenum. The discovery, characterized by extensive mineralization and strategic metal zonation, is shaping up as a potential Tier 1 resource with strong commercial appeal.

Northern Minerals has made significant progress on its Browns Range Heavy Rare Earths Project, advancing its feasibility study and exploration while raising $41.5 million, positioning itself as a strategic alternative amid growing geopolitical supply risks.

AnteoTech Ltd reports progress in advanced battery and life sciences technologies alongside a strategic review and leadership changes amid challenging EV market conditions.

Percheron Therapeutics has discontinued its ATL1103 program and curtailed investment in ATL1102 following underwhelming trial results, while advancing talks to in-license new rare disease therapies and extending its cash runway into FY2027.

Syntara Limited reports significant clinical progress with its lead myelofibrosis drug SNT-5505 and launches a new trial for its next-generation anti-fibrotic skin treatment, supported by a solid $18 million cash reserve.

AustChina Holdings has completed the acquisition of Penwortham Exploration, gaining full control of promising gold-antimony and base metals projects in Tasmania, and has commenced exploration activities in a prolific mining region.

Anteris Technologies Global Corp. has filed an amended 10-K to disclose comprehensive governance, executive pay, and related party transactions for fiscal 2024, completing its annual SEC reporting obligations.

Galan Lithium has locked in a binding funding and offtake agreement with Authium Limited for its Hombre Muerto West project, significantly reducing capital and operating costs. The company raised approximately A$13 million via placement and plans further shareholder funding, aiming for lithium chloride production in H1 2026.